Braftovi 75 MG capsule 90S
Ended Awarded
- Contract number
- SPE2DX25FVJVD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $90,504
Award facts
- Contract value 100% obligated
- $90,504.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitively-sourced delivery order valued at $90,504.08 on September 10, 2025, for the supply of Braftovi 75 mg capsules (90-count units). The contract, which operates under firm fixed-price terms with an ultimate completion date of October 1, 2025, is funded by the Defense Logistics Agency's Medical Supply Chain division and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. No set-aside designation was applied to this award, indicating the contract was awarded through open competition.
This delivery order supports the federal government's pharmaceutical procurement needs for military and veteran healthcare systems, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania location. Braftovi (encorafenib), a targeted cancer therapy, will be distributed through the DLA Medical Supply Chain to support Defense Health Agency operations and other federal healthcare customers. The award reflects AmerisourceBergen's established capability as a critical pharmaceutical vendor for federal medical procurement, as evidenced by its extensive portfolio of competitively-awarded contracts spanning brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DX25FVJVD?
SPE2DX25FVJVD was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on September 10, 2025.
How much is contract SPE2DX25FVJVD worth?
The government has obligated $90,504 on SPE2DX25FVJVD.
Is contract SPE2DX25FVJVD an order under another contract?
Yes. SPE2DX25FVJVD is a delivery order under SPE2DX15D1022, an indefinite delivery contract.
Was contract SPE2DX25FVJVD competed?
The extent of competition for SPE2DX25FVJVD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award